Bone Metastatic Castration-resistant Prostate Cancer

4 clinical trials · Condition

Record	Firm	Date
A Study to Learn More About How Radium-223 is Being Used With Other Treatments in European Patients Who Have Not Received Radium-223 Before (NCT04587427)	Bayer	2021-05-15
A Study to Assess How Radium-223 Distributes in the Body of Patients With Prostate Cancer Which Spread to the Bones (NCT04521361)	Bayer	2020-11-16
Pharmacodynamic Study of Radium-223 in Men With Bone Metastatic Castration-Resistant Prostate Cancer (NCT02204943)	Duke University	2015-05-06
Safety and Efficacy Study of KX2-391 for Treatment of Bone-Metastatic, Castration-Resistant Prostate Cancer (NCT01074138)	Athenex, Inc.	2010-02-01

Every clearance here is in the API, with alerts when new ones post.